Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis
- 307 Downloads
Neurocutaneous melanosis (NCM) is a very rare congenital syndrome characterized by large or multiple congenital melanocytic nevi (CMN) of the skin and central nervous system (CNS) melanotic/melanocytic lesions. The latter range from intraparenchymal melanin deposits to benign or malignant proliferations of melanocytic cells in the leptomeninges that may be localized (melanocytoma/melanoma) or diffuse (melanocytosis/melanomatosis) [3, 7]. Once NCM patients develop neurological symptoms, prognosis is usually poor, especially for CNS melanoma, but also symptomatic (and histologically confirmed ‘benign’) melanocytosis often has a poor prognosis . As such, histological features of CNS melanocytic tumours (CNS-MTs) do not correlate very well with clinical outcome in NCM patients, and at present, molecular features that might aid in this are lacking.
In contrast to cutaneous lesions in NCM, it is unknown whether CNS-MTs harbor copy number variations (CNVs) with diagnostic and/or prognostic...
KeywordsMelanoma Copy Number Variation Cutaneous Melanoma Copy Number Loss Primary Cutaneous Melanoma
This work was supported by a research grant from the Koppie-Au foundation, Breda, The Netherlands.
Compliance with ethical standards
Conflict of interest
The authors state no conflict of interest.
- 3.Brat DJ, Perry A, Wesseling P, Bastian BC (2016) Melanocytic tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 266–270Google Scholar
- 5.Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Slater O et al (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133:2229–2236CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Kusters-Vandevelde HV, Willemsen AE, Groenen PJ, Kusters B, Lammens M, Wesseling P, Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA et al (2014) Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta Neuropathol Commun 2:41CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA (2015) Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol 173:739–750CrossRefPubMedPubMedCentralGoogle Scholar